Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at BTIG Research.
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference [Yahoo! Finance]
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS